Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis

Lancet

Volumn 370, Issue 9581, 2007, Pages 59-67

  Grulich, Andrew E ^a   van Leeuwen, Marina T ^a   Falster, Michael O ^a   Vajdic, Claire M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; EPITHELIUM TUMOR; GRAFT RECIPIENT; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION SENSITIVITY; LIVER CANCER; ORGAN TRANSPLANTATION; POPULATION RESEARCH; PRIORITY JOURNAL; STOMACH CANCER; WART VIRUS;

EID: 34347323902     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61050-2     Document Type: Article

References (30)

1. Biggar R., Jaffe E., Goedert J., Chaturvedi A., Pfeiffer R., and Engels E. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 108 (2006) 3786-3791
2. Grulich A., Li Y., McDonald A., Correll P., Law M., and Kaldor J. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 16 (2002) 1155-1161
3. Frisch M., Biggar R., and Goedert J. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92 (2000) 1500-1510
4. Frisch M., Biggar R., Engels E., and Goedert J. Association of cancer with AIDS-related immunosuppression in adults. JAMA 285 (2001) 1736-1745
5. Vajdic C., McDonald S., McCredie M., et al. Cancer incidence before and after kidney transplantation. JAMA 296 (2006) 2823-2831
6. Villeneuve P., Schaubel D., Fenton S., Shepherd F., Jiang Y., and Mao Y. Cancer incidence among canadian kidney transplant recipients. Am J Transplant 7 (2007) 941-948
7. Stroup D., Berlin J., Morton S., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283 (2000) 2008-2012
8. Cooksley C., Hwang L., Waller D., and Ford C. HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS 10 (1999) 795-802
9. Engels E., Pfeiffer R., Goedert J., et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 20 (2006) 1645-1654
10. Dal Maso L., Franceschi S., Polesel J., et al. Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer 89 (2003) 94-100
11. Parkin D. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118 (2006) 3030-3044
12. Deeks J.A., and Bradburn M. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M., Davey-Smith D., and Altman D. (Eds). Systematic reviews in health care. 2nd edn (2001), BMJ Books, London 285-312
13. Higgins J., and Thompson S. Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002) 1539-1558
14. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
15. Allardice G., Hole D., Brewster D., Boyd J., and Goldberg D. Incidence of malignant neoplasms among HIV-infected persons in Scotland. Br J Cancer 89 (2003) 505-507
16. Clifford G., Polesel J., Rickenbach M., et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97 (2005) 425-432
17. Newnham A., Harris J., Evans H., Evans B., and Moller H. The risk of cancer in HIV-infected people in southeast England: a cohort study. Br J Cancer 92 (2005) 194-200
18. Birkeland S., Lokkegaard H., and Storm H. Cancer risk in patients on dialysis and after renal transplantation. Lancet 355 (2000) 1886-1887
19. Kyllonen L., Salmela K., and Pukkala E. Cancer incidence in a kidney-transplanted population. Transpl Int 13 suppl 1 (2000) S394-S398
20. Adami J., Gabel H., Lindelof B., et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 89 (2003) 1221-1227
21. Moore P., and Chang Y. Kaposi's sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology. Am J Epidemiol 147 (1998) 217-221
22. Harwood C., Surentheran T., Sasieni P., et al. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 150 (2004) 949-957
23. Cogliano V., Baan R., Straif K., Grosse Y., Secretan B., and El Ghissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol 6 (2005) 204
24. Kinlen L. Infections and immune factors in cancer: the role of epidemiology. Oncogene 23 (2004) 6341-6348
25. Gillison M., and Shah K. Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr 31 (2003) 57-65
26. Kasiske B., and Klinger D. Cigarette smoking in renal transplant recipients. J Am Soc Nephrol 11 (2000) 753-759
27. Friis-Moller N., Sabin C., Weber R., et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349 (2003) 1993-2003
28. Grulich A., Olsen S., Luo K., et al. Kaposi's sarcoma-associated herpesvirus: a sexually transmissible infection?. J Acquir Immune Defic Syndr Hum Retrovirol 20 (1999) 387-393
29. Yeni P., Cooper D., Aboulker J.-P., et al. Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial. Lancet 368 (2006) 287-298
30. Burnet F. The concept of immunological surveillance. Prog Exp Tumor Res 13 (1970) 1-27